# The Fondazione Genomic SARS-CoV-2 Study COVID-19

> **NCT06549712** · NA · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 4000 (actual)

## Conditions studied

- COVID-19
- Genetic Predisposition

## Interventions

- **GENETIC:** genetic determinants to develop respiratory failure
- **GENETIC:** genetic determinants to develop respiratory failure
- **GENETIC:** genetic determinants to develop respiratory failure

## Key facts

- **NCT ID:** NCT06549712
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-23
- **Primary completion:** 2021-01-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 4000 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549712, "The Fondazione Genomic SARS-CoV-2 Study COVID-19". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06549712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*